 |
|
|
| |
Once-Daily Oral GSK1265744 (744) as Part of Combination Therapy in Antiretroviral-Naive Adults: 24-Week Safety and Efficacy Results From the LATTE Study (LAI116482)
|
| |
| |
Reported by Jules Levin
EACS 14th European AIDS Conference 2013 Oct 16-19 Brussels, Belgium
David Margolis,1 Laveeza Bhatti,2 Graham Smith,3 Winkler Weinberg,4
Cynthia Brinson,5 Tony Mills,6 Edwin DeJesus,7 Britt Stancil,1 Paul Wannamaker,1 Melinda Bomar,1 Marty St Clair,1 William Spreen,1 James Goodrich8
1GlaxoSmithKline, Research Triangle Park, NC, USA; 2AIDS Healthcare Foundation, Beverly Hills, CA, USA; 3Maple Leaf Medical Clinic, Toronto, Canada; 4Kaiser Permanente, Atlanta, GA, USA; 5Central Texas Clinical Research, Austin, TX, USA; 6Anthony Mills MD Inc, Los Angeles, CA, USA; 7Orlando Immunology Center, Orlando, FL, USA; 8ViiV Healthcare, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
